WALTHAM, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next ...
Milestone validates the clinical potential of BSI-082 as a synergistic combination partner for antibody-drug conjugates (ADCs) and reinforces Biosion's "In Global, For Global" collaboration strategy.
Last summer, the Dalai Lama was having a party in Dharamshala for his 90th birthday, and Bethany Morrison, a newly appointed State Department official, was eager to meet with him there. Inconveniently ...
The paramedics did almost everything right. They responded to a call for an unconscious man slumped on a bus bench. He was barely breathing. His pupils were pinpoint. The signs pointed to a narcotics ...
Kivu Bioscience Announces First Patient Dosed in Phase 1 Trial of KIVU-107 Next-Generation PTK7-Targeting ADC for Advanced Solid Tumors Kivu Bioscience, a clinical-stage biotechnology company ...
Pushback is mounting against new federal student-loan reforms passed under the One Big Beautiful Bill Act, with lawmakers warning the policy could further strain the nursing workforce. In a Dec. 12 ...
A nonprofit providing legal aid to low-income South Dakotans will retain its federal funding, despite claims of ineffectiveness from a fellow legal aid organization. The decision leaves South Dakota’s ...
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--The first patient has been dosed in the randomization phase of the DESTINY-Ovarian01 phase 3 trial evaluating ENHERTU ® (trastuzumab deruxtecan) in ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Exercise can help women with advanced breast cancer better withstand both cancer treatments and the ravages of the disease, a new clinical trial shows. A nine-month program of supervised aerobic and ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It's the first spinoff in ...